Back to search
Active Ankylosing Spondylitis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Active Ankylosing Spondylitis trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Active Ankylosing Spondylitis trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Xeljanz XR extended-release tablets 11 mg (Tofacitinib citrate) is a drug subject to the risk management plan in accordance with Article 4-1-11 of the "Regulati…
The purpose of this study is to assess plasma bimekizumab concentrations following subcutaneous (sc) bimekizumab administration.
The purpose of this study is to evaluate the safety and efficacy of secukinumab 300mg in Chinese adults participants with active ankylosing spondylitis (AS) who…
This clinical trial is a multicenter, randomized, double-blind, controlled phase III clinical study.
This study will evaluate the efficacy and safety of 608 in patients with AS.
The aim of this study is to evaluate the efficacy and safety of LNK01001 in subjects with active ankylosing spondylitis. The study is comprised of a 16-week ra…
Psoriatic arthritis (PsA) and ankylosing spondylitis (AS) are chronic inflammatory diseases within the spectrum of spondyloarthritis, characterized by immune-me…
The purpose of this study is to evaluate preliminary efficacy, safety pharmacokinetic (PK) characteristics, pharmacodynamics (PD) haracteristics and immunogenic…